Kathrin Kalies Selected Research

Virus Diseases (Viral Diseases)

12/2017

Nanoparticles prepared from porcine cells support the healing of cutaneous inflammation in mice and wound re-epithelialization in human skin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kathrin Kalies Research Topics

Disease

19	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2022 - 11/2011
13	Inflammation (Inflammations) 05/2022 - 01/2016
11	Autoimmune Diseases (Autoimmune Disease) 02/2023 - 09/2012
8	Blister (Bulla) 01/2020 - 09/2013
5	Skin Diseases (Skin Disease) 12/2020 - 01/2013
4	Infections 02/2023 - 02/2012
4	Bullous Pemphigoid (Pemphigoid) 01/2022 - 01/2017
3	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 04/2015 - 02/2013
2	Tertiary Lymphoid Structures 01/2018 - 02/2011
2	Colitis 11/2017 - 11/2013
1	Food Hypersensitivity (Food Allergy) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Egg Hypersensitivity (Egg Allergy) 01/2022
1	Sleep Deprivation 05/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2018
1	Vasculitis (Vasculitides) 01/2018
1	Microscopic Polyangiitis 01/2018
1	Neoplasms (Cancer) 12/2017
1	Virus Diseases (Viral Diseases) 12/2017
1	Ulcerative Colitis 08/2017
1	Carcinogenesis 08/2017
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Disease Progression 02/2017
1	Pneumococcal Infections 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2013
1	Rheumatoid Arthritis 02/2013
1	Lupus Nephritis 04/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2012
1	Nephritis 04/2012

Drug/Important Bio-Agent (IBA)

17	AutoantibodiesIBA 02/2023 - 04/2012
11	Collagen Type VIIIBA 01/2020 - 11/2011
7	CytokinesIBA 01/2020 - 02/2012
5	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 04/2012
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2011
4	Immunoglobulin G (IgG)IBA 01/2022 - 04/2012
3	AutoantigensIBA 02/2023 - 01/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2020 - 12/2016
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2022
2	IgG Receptors (Fc gamma RI)IBA 01/2022 - 01/2017
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2017
2	Therapeutic UsesIBA 01/2022 - 12/2017
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2017 - 11/2013
2	Dextrans (Dextran)FDA Link 11/2017 - 11/2013
2	AntibodiesIBA 02/2017 - 11/2011
2	Interleukin-6 (Interleukin 6)IBA 04/2015 - 02/2013
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2023
1	Peptides (Polypeptides)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 01/2022
1	parsaclisibIBA 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 12/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	Myeloblastin (Proteinase 3)IBA 01/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 12/2017
1	Biomarkers (Surrogate Marker)IBA 11/2017
1	Etanercept (Enbrel)FDA Link 02/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2017
1	tanespimycin (17AAG)IBA 01/2017
1	anti-type VII collagen autoantibodyIBA 01/2017
1	Chemotactic FactorsIBA 01/2017
1	LipidsIBA 01/2017
1	Leukotriene B4IBA 01/2017
1	EnzymesIBA 01/2017
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2017
1	Interleukin-10 ReceptorsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	AnaphylatoxinsIBA 01/2016
1	Member 1 Group F Nuclear Receptor Subfamily 1IBA 09/2015
1	Interleukin-1 (Interleukin 1)IBA 04/2015
1	Adenosine Triphosphate (ATP)IBA 11/2013
1	Trinitrobenzenesulfonic AcidIBA 11/2013
1	Transcription Factors (Transcription Factor)IBA 11/2013
1	Mitochondrial DNA (mtDNA)IBA 11/2013
1	SaltsIBA 09/2013
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 02/2013
1	Complement System Proteins (Complement)IBA 11/2011
1	Type I Tumor Necrosis Factor ReceptorsIBA 02/2011

Therapy/Procedure

1	Oral Administration 11/2017
1	Therapeutics 04/2015